{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:10:52Z","timestamp":1790439052576,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16362-1","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:15:29Z","timestamp":1755814529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Artificial intelligence model for predicting early biochemical recurrence of prostate cancer after robotic-assisted radical prostatectomy"],"prefix":"10.1038","volume":"15","author":[{"given":"Miguel Angel","family":"Bergero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Modina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Hosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenceslao","family":"Villamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Gudi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"3","key":"16362_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"15","key":"16362_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy, F. C. et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. New Engl. J. Med. 375(15), 1415\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa1606220 (2016).","journal-title":"New Engl. J. Med."},{"issue":"2","key":"16362_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1615869","volume":"377","author":"TJ Wilt","year":"2017","unstructured":"Wilt, T. J. et al. Follow-up of prostatectomy versus observation for early prostate cancer. N. Engl. J. Med. 377(2), 132\u2013142. https:\/\/doi.org\/10.1056\/NEJMoa1615869 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"16362_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/cncr.25013","volume":"116","author":"TK Choueiri","year":"2010","unstructured":"Choueiri, T. K. et al. Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer 116(8), 1887\u20131892. https:\/\/doi.org\/10.1002\/cncr.25013 (2010).","journal-title":"Cancer"},{"issue":"4","key":"16362_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.eururo.2017.12.023","volume":"74","author":"WC Jackson","year":"2018","unstructured":"Jackson, W. C. et al. Intermediate endpoints after postprostatectomy radiotherapy: 5-year distant metastasis to predict overall survival. Eur Urol. 74(4), 413\u2013419. https:\/\/doi.org\/10.1016\/j.eururo.2017.12.023 (2018).","journal-title":"Eur Urol."},{"issue":"3","key":"16362_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.eururo.2015.04.016","volume":"69","author":"AE Ross","year":"2016","unstructured":"Ross, A. E. et al. Utility of risk models in decision making after radical prostatectomy: Lessons from a natural history cohort of intermediate- and high-risk men. Eur. Urol. 69(3), 496\u2013504. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.016 (2016).","journal-title":"Eur. Urol."},{"key":"16362_CR7","doi-asserted-by":"crossref","unstructured":"Tilki, D. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: Treatment of relapsing and metastatic prostate cancer. Eur Urol. 86(2), 164\u2013182 (2024).","DOI":"10.1016\/j.eururo.2024.04.010"},{"issue":"2","key":"16362_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.eururo.2008.05.024","volume":"54","author":"FK Chun","year":"2008","unstructured":"Chun, F. K., Karakiewicz, P. I. & Briganti, A. Prostate cancer diagnosis: Importance of individualized risk stratification models over PSA alone. Eur. Urol. 54(2), 241\u2013242. https:\/\/doi.org\/10.1016\/j.eururo.2008.05.024 (2008).","journal-title":"Eur. Urol."},{"issue":"11","key":"16362_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11), 969\u2013974. https:\/\/doi.org\/10.1001\/jama.280.11.969 (1998).","journal-title":"JAMA"},{"issue":"6","key":"16362_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0090-4295(01)00978-5","volume":"57","author":"WW Roberts","year":"2001","unstructured":"Roberts, W. W. et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 57(6), 1033\u20131037. https:\/\/doi.org\/10.1016\/s0090-4295(01)00978-5 (2001).","journal-title":"Urology"},{"issue":"10","key":"16362_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/jnci\/90.10.766","volume":"90","author":"MW Kattan","year":"1998","unstructured":"Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. & Scardino, P. T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 90(10), 766\u2013771. https:\/\/doi.org\/10.1093\/jnci\/90.10.766 (1998).","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"16362_CR12","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","volume":"173","author":"MR Cooperberg","year":"2005","unstructured":"Cooperberg, M. R. et al. The University of California, San Francisco Cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J. Urol. 173(6), 1938\u20131942. https:\/\/doi.org\/10.1097\/01.ju.0000158155.33890.e7 (2005).","journal-title":"J. Urol."},{"issue":"6","key":"16362_CR13","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/01.ju.0000127733.01845.57","volume":"171","author":"KL Greene","year":"2004","unstructured":"Greene, K. L. et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community-based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J. Urol. 171(6), 2255\u20132259. https:\/\/doi.org\/10.1097\/01.ju.0000127733.01845.57 (2004).","journal-title":"J. Urol."},{"issue":"5","key":"16362_CR14","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/j.clgc.2017.06.001","volume":"15","author":"JM Campbell","year":"2017","unstructured":"Campbell, J. M. et al. Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Clin. Genitourin. Cancer. 15(5), e827\u2013e834. https:\/\/doi.org\/10.1016\/j.clgc.2017.06.001 (2017).","journal-title":"Clin. Genitourin. Cancer."},{"issue":"13","key":"16362_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005.PMID:25750696;PMCID:PMC4348437","volume":"15","author":"K Kourou","year":"2014","unstructured":"Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V. & Fotiadis, D. I. Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J. 15(13), 8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005.PMID:25750696;PMCID:PMC4348437 (2014).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"385","key":"16362_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378.Erratum.In:BMJ.2024Apr18;385:q902.doi:10.1136\/bmj.q902.PMID:38626948;PMCID:PMC11019967","volume":"16","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 16(385), e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378.Erratum.In:BMJ.2024Apr18;385:q902.doi:10.1136\/bmj.q902.PMID:38626948;PMCID:PMC11019967 (2024).","journal-title":"BMJ"},{"issue":"1","key":"16362_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff, R. F. et al. PROBAST: A tool to assess the risk of bias and applicability of prediction model studies. Ann. Intern. Med. 170(1), 51\u201358. https:\/\/doi.org\/10.7326\/M18-1376 (2019).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"16362_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.eururo.2024.04.034","volume":"86","author":"AB Weiner","year":"2024","unstructured":"Weiner, A. B. et al. Risk stratification of patients with recurrence after primary treatment for prostate cancer: A systematic review. Eur. Urol. 86(3), 200\u2013210 (2024).","journal-title":"Eur. Urol."},{"key":"16362_CR19","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00345-019-03000-5","volume":"38","author":"R Suarez-Ibarrola","year":"2020","unstructured":"Suarez-Ibarrola, R., Hein, S., Reis, G., Gratzke, C. & Miernik, A. Current and future applications of machine and deep learning in urology: A review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer. World J Urol. 38, 2329\u20132347 (2020).","journal-title":"World J Urol."},{"issue":"6 Pt 1","key":"16362_CR20","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/01.ju.0000127733.01845.57","volume":"171","author":"KL Greene","year":"2004","unstructured":"Greene, K. L. et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community-based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol. 171(6 Pt 1), 2255\u20132259. https:\/\/doi.org\/10.1097\/01.ju.0000127733.01845.57 (2004).","journal-title":"J Urol."},{"issue":"5","key":"16362_CR21","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/j.clgc.2017.06.001","volume":"15","author":"JM Campbell","year":"2017","unstructured":"Campbell, J. M. et al. Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Clin. Genitourin. Cancer. 15(5), e827\u2013e834. https:\/\/doi.org\/10.1016\/j.clgc.2017.06.001 (2017).","journal-title":"Clin. Genitourin. Cancer."},{"issue":"1","key":"16362_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/bju.14477","volume":"123","author":"NC Wong","year":"2019","unstructured":"Wong, N. C., Lam, C., Patterson, L. & Shayegan, B. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy. BJU Int. 123(1), 51\u201357 (2019).","journal-title":"BJU Int."},{"key":"16362_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0302-2838(21)01542-6","volume":"79","author":"M Eski","year":"2021","unstructured":"Eski, M. et al. Machine learning algorithms can more efficiently predict biochemical recurrence after robot assisted radical prostatectomy. Eur Urol. 79, 1651 (2021).","journal-title":"Eur Urol."},{"issue":"3","key":"16362_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/pros.24272","volume":"82","author":"YG Tan","year":"2022","unstructured":"Tan, Y. G. et al. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy. Prostate 82(3), 298\u2013305 (2022).","journal-title":"Prostate"},{"issue":"4","key":"16362_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/app10041333","volume":"10","author":"SJ Lee","year":"2020","unstructured":"Lee, S. J. et al. Prediction system for prostate cancer recurrence using machine learning. Appl. Sci. 10(4), 1333 (2020).","journal-title":"Appl. Sci."},{"key":"16362_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1200\/CCI.20.00137.PMID:33739856;PMCID:PMC8462624","volume":"5","author":"Q Chen","year":"2021","unstructured":"Chen, Q. et al. Clinical data prediction model to identify patients with early-stage pancreatic cancer. JCO Clin. Cancer Inform. 5, 279\u2013287. https:\/\/doi.org\/10.1200\/CCI.20.00137.PMID:33739856;PMCID:PMC8462624 (2021).","journal-title":"JCO Clin. Cancer Inform."},{"issue":"2022","key":"16362_CR27","doi-asserted-by":"publisher","first-page":"8501819","DOI":"10.1155\/2022\/8501819.PMID:36277898;PMCID:PMC9581702","volume":"12","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. a machine learning approach using XGBoost predicts lung metastasis in patients with ovarian cancer. Biomed. Res. Int. 12(2022), 8501819. https:\/\/doi.org\/10.1155\/2022\/8501819.PMID:36277898;PMCID:PMC9581702 (2022).","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"16362_CR28","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.surg.2021.12.015","volume":"171","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Preoperative prediction for lymph node metastasis in early gastric cancer by interpretable machine learning models: A multicenter study. Surgery 171(6), 1543\u20131551. https:\/\/doi.org\/10.1016\/j.surg.2021.12.015 (2022).","journal-title":"Surgery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16362-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:58:25Z","timestamp":1757444305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16362-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16362-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients enrolled in the study voluntarily signed an informed consent form regarding the use of their data in accordance with the principles of the Declaration of Helsinki, complying with the standards and protocols for conducting human research established by the Ethics Committee of the Italian Hospital of Buenos Aires.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"30822"}}